80 related articles for article (PubMed ID: 9369088)
1. Pap smear concerns.
Moran T
Tex Med; 1997 Nov; 93(11):44-6. PubMed ID: 9369088
[No Abstract] [Full Text] [Related]
2. Companies build Pap smear safety nets.
Scott L
Mod Healthc; 1995 May; 25(19):70. PubMed ID: 10142267
[No Abstract] [Full Text] [Related]
3. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories.
Krieger P; Naryshkin S
Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815
[No Abstract] [Full Text] [Related]
4. Of Pap smears and managed care.
Strama T
Tex Med; 1998 Jan; 94(1):6. PubMed ID: 9448446
[No Abstract] [Full Text] [Related]
5. Strategies for integrated health care systems.
Coddington DC; Fischer EA; Moore KD
Healthc Leadersh Manag Rep; 2001 Nov; 9(11):8-15. PubMed ID: 11828594
[No Abstract] [Full Text] [Related]
6. Why women still die from cervical cancer.
Masood S
J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
[TBL] [Abstract][Full Text] [Related]
7. Using urbanization profiles to assess screening performance.
Boon ME; Kok LP
Diagn Cytopathol; 2004 Apr; 30(4):243-6. PubMed ID: 15048958
[TBL] [Abstract][Full Text] [Related]
8. Pap smear furor may derail Clinton changes.
Scott L
Mod Healthc; 1993 Oct; 23(40):17. PubMed ID: 10171532
[No Abstract] [Full Text] [Related]
9. [External quality control in cervical cytopathology: an evaluation from 2000-2004].
Rev Saude Publica; 2007 Dec; 41(6):1071. PubMed ID: 18066478
[No Abstract] [Full Text] [Related]
10. Understanding the financial impact of covering new screening technologies. The case of automated Pap smears.
McQuarrie HG; Ogden J; Costa M
J Reprod Med; 2000 Nov; 45(11):898-906. PubMed ID: 11127101
[TBL] [Abstract][Full Text] [Related]
11. Replies to questions on Quality Assurance Measures in Cytopathology.
Acta Cytol; 1989; 33(4):559-61. PubMed ID: 2750444
[No Abstract] [Full Text] [Related]
12. HMOs should stress quality tests in light of pap smear controversy.
Johnson DE
Contract Healthc; 1988 Feb; ():27. PubMed ID: 10318142
[No Abstract] [Full Text] [Related]
13. [Managed care, control of costs and the patient's health].
Simonet D
Rev Med Suisse Romande; 2001 Apr; 121(4):269-75. PubMed ID: 11400398
[TBL] [Abstract][Full Text] [Related]
14. Does managed care jeopardize quality?
Health Care Food Nutr Focus; 1997 Aug; 13(12):1, 3. PubMed ID: 10169217
[No Abstract] [Full Text] [Related]
15. Special report. Integrating managed care. Managed care is more than cost containment.
Simpson R
Bus Health; 1991; [integrating]():8-9. PubMed ID: 10113070
[No Abstract] [Full Text] [Related]
16. Are class 1 and class 2 Pap smears objectively interpreted?
Berube LW
Md State Med J; 1973 Sep; 22(9):54-8. PubMed ID: 4774187
[No Abstract] [Full Text] [Related]
17. Medical standard of care jurisprudence as evolutionary process: implications under managed care.
Markowitz C
Yale J Health Policy Law Ethics; 2001; 2(1):59-88. PubMed ID: 12664937
[No Abstract] [Full Text] [Related]
18. Pap smear process and quality assessment.
Snyder K; Greensher A; Raye CH; Fletcher L
Fam Med; 1993 Sep; 25(8):490-1. PubMed ID: 8405792
[No Abstract] [Full Text] [Related]
19. Quality & access in the managed behavioral healthcare industry.
Marques C; Geraty R; Harbin H; Hoover K; Theis J
Behav Healthc Tomorrow; 1994; 3(5):22-9. PubMed ID: 10141166
[TBL] [Abstract][Full Text] [Related]
20. Escalating health care costs: managed care organizations.
Wehrmacher WH; Leimbach WN
Compr Ther; 1998; 24(11-12):596-600. PubMed ID: 9847977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
